Corpus Intelligence IC Memo — VIA CHRISTI HOSP. WICHITA ST. TERESA 2026-04-26 05:22 UTC
IC Memo — VIA CHRISTI HOSP. WICHITA ST. TERESA
Investment Committee Memorandum | KS | 38 beds | Grade C | EBITDA uplift $4.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

VIA CHRISTI HOSP. WICHITA ST. TERESA

CCN 170200 | SEDGWICK, KS | 38 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

VIA CHRISTI HOSP. WICHITA ST. TERESA is a 38-bed suburban community hospital in SEDGWICK, KS with $55.1M in net patient revenue and a 16.7% operating margin. The hospital serves a payer mix of 52.3% Medicare, 2.5% Medicaid, and 45.2% commercial.

Thesis: Turnaround. Our ML models identify $4.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 16.7% to 24.0% (+736bps).

Net Revenue HCRIS$55.1M
Current EBITDA COMPUTED$9.2M
Operating Margin COMPUTED16.7%
Occupancy HCRIS59.5%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS23.6%
Distress Probability ML45.3%

2. Market Context & Competitive Position

152
KS Hospitals
-17.7%
State Median Margin
93
Comparable Hospitals

KS has 152 Medicare-certified hospitals with a median operating margin of -17.7%. The target's margin of 16.7% places it above the state median. Among 93 size-comparable peers (19-76 beds), the median margin is -19.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (19-76), prioritizing same-state peers. 93 hospitals in the comp set.

HospitalStateBedsRevenueMargin
VIA CHRISTI HOSP. WICHITA ST. (Target)KS38$55.1M16.7%
CHILDRENS MERCY HOSPITAL KANSAKS42$108.5M14.7%
NEWTON MEDICAL CENTERKS76$93.2M-7.9%
VIA CHRISTI HOSPITAL PITTSBURGKS64$90.4M-16.9%
LABETTE COUNTY MEDICAL CENTERKS49$80.6M-14.3%
NEWMAN REGIONAL HEALTHKS23$73.9M-15.6%
KANSAS SPINE & SPECIALTY HOSPIKS35$69.6M19.1%
SOUTHWEST MEDICAL CENTERKS67$62.9M-22.9%
KANSAS SURGERY & RECOVERY CENTKS30$62.8M20.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.2M+210bp18mo
Cost to Collect4.5%2.5%$1.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$670K+122bp9mo
Clean Claim Rate88.0%96.0%$35K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.2M
Cost to Collect
$1.1M
Denial Rate Reduction
$1.1M
A/R Days Reduction
$670K
Clean Claim Rate
$35K
Total EBITDA Uplift$4.1M
Current EBITDA$9.2M
+ RCM Uplift+$4.1M
Pro Forma EBITDA$13.2M
Current Margin16.7%
Pro Forma Margin24.0%
WC Released (1x)$2.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$14.1M$101.1M7.16x48.2%
Base (11x exit)10.0x11.0x$14.1M$115.8M8.20x52.3%
Bull Case9.0x11.0x$12.7M$133.8M10.52x60.1%
Bull (12x exit)9.0x12.0x$12.7M$149.7M11.77x63.7%
Bear Case11.0x10.0x$15.5M$76.3M4.91x37.5%
Bear (11x exit)11.0x11.0x$15.5M$88.9M5.72x41.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 93 hospitals with 19-76 beds
  • Same-state prioritization (n=94)
  • Comp margins: P25=-30.5% / P50=-19.1% / P75=-8.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.